Alnylam BioVenture Challenge Highlight: Claire Zeng
The 2025 Alnylam BioVenture Challenge event will take place at Alnylam’s headquarters in Boston, MA. Selected participants will be invited to network with Alnylam executives and scientists and compete for $100,000 USD in non-dilutive grant funding.
At this session, join to hear from Claire Zeng, Founder at DoriNano, and a 2022 winner of the Alnylam BioVenture Challenge!
Focus areas for this year's Challenge span Innovative Genetic Medicine, Delivery Technologies, and Target Discovery Innovation. Researchers interested in being considered should submit their proposals at INSERT before DATE.
Applicants at all stages of technology development are encouraged to apply! Affiliation with Nucleate is not an application prerequisite. International teams are welcome to apply.
Attend the info session to learn more about this opportunity and get all your questions answered!
About the Host:
Nucleate is a 501(c)(3) nonprofit organization dedicated to empowering the next generation of biotech leaders. With chapters spanning 41 geographic regions and participation from over 280 academic institutions, Nucleate sparks new intellectual communities and embeds emerging talent within a global biotech community. Through open-access educational programming, Nucleate helps democratize biotech innovation — removing barriers and helping founders concentrate on building transformational technologies. Visit www.nucleate.xyz for more information, and visit https://nucleate.xyz/privacy-policy/ to read our privacy policy.
We want to thank our HQ supporters for championing our open-access mission and empowering the next generation of biotech entrepreneurs!
Platinum: Eli Lilly and Company, Genentech, Alnylam Pharmaceuticals, MilliporeSigma
Philanthropic Support: Lyda Hill Philanthropies
Preferred Partners: Pillar VC, Amino Collective, Excedr, Mercury, Brex, Fedsprout
In-Kind Support: AcademicLabs, Lens.org, SynBioBeta